What type of study is this?

This is a Human Clinical Trial study.

September 10, 2025

Role of Ashvatha Phala Churna And Shveta Palandu Swarasa Bhavita Yavani in the Management of Ksheena Shukra (Oligozoospermia) after Shodhana Therapy - Clinical Study

Key Points

Both treatments improved sperm count significantly, with Shveta Palandu Swarasa showing a 65% increase.
Treatment with Ashvatha Phala Churna resulted in a 59.78% increase in sperm count after 60 days.
Virechana Karma was carried out before administering both treatments to enhance effects.
Shveta Palandu Swarasa showed greater efficacy compared to Ashvatha Phala Churna in managing oligozoospermia.

Abstract

Almost 30% of cases of infertility will have a male factor attached to it, though in the society there are many misconceptions and wrong ideas regarding the cause and occurrence of infertility in men. A low sperm count is in no way related to weakness or one being abnormal, hence the semen count needs to be assessed and the cause for it being low should be determined as timely treatment can not only prevent it from falling further but counts may improve. Aims 19 patients were treated with 4 Vati twice a day with Goghrita for 60 days. Provided increase in sperm count (65%), and abnormal form of sperm (20.74%) decrease .Conclusion: Both the trial drugs Ashwattha Phala Churna and Shveta Palandu Swarasa Bhavita Yavani Vati have definite role in the management of Ksheena Shukra when administered after Virechana Karma, But Shveta Palandu Swarasa Bhavita Yavani Vati is comparatively better than Ashwattha Phala Churna.

Mark Helpful

Bookmark

Relay